BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 91266)

  • 1. A new case of gamma heavy chain disease: clinical, immunochemical and structural characterization.
    Carbonara AO; Paolino W; Malavasi F; Levis A; Stramignoni A; de Lange G; van Loghem E; Franklin EC
    Vox Sang; 1979; 37(2):89-95. PubMed ID: 91266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new case of gamma-3 heavy chain disease. Biochemical and immunological investigations.
    Biewenga J; van Loghem E
    Vox Sang; 1979; 36(4):193-8. PubMed ID: 88813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunochemical and structural characterization of an IgG1 heavy chain disease.
    Sala P; Tonutti E; Pizzolitto S; Noda S; Putnam FW; De Lange G; Boccazzi C; Bottaro A; Carbonara AO
    Ric Clin Lab; 1989; 19(1):59-65. PubMed ID: 2503864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal IgM cryoglobulinemia associated with gamma-3 heavy chain disease: immunochemical and biochemical studies.
    Wang AC; Arnaud P; Fudenberg HH; Creyssel R
    Eur J Immunol; 1978 Jun; 8(6):375-9. PubMed ID: 97087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunochemical study of a human myeloma IgG1 half molecule.
    Seligmann M; Mihaesco E; Chevalier A; Miglierina R
    Ann Immunol (Paris); 1978; 129 C(6):855-70. PubMed ID: 85430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gamma heavy chain disease in man: synthesis of a deleted gamma3 immunoglobulin by lymphoid cells in short and long term tissue culture.
    Buxbaum JN; Alexander A; Olivier O
    Clin Exp Immunol; 1978 Jun; 32(3):489-97. PubMed ID: 80297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence of ovine Ig gamma 2 constant region heavy chain cDNA and molecular modelling of ruminant IgG isotypes.
    Clarkson CA; Beale D; Coadwell JW; Symons DB
    Mol Immunol; 1993 Sep; 30(13):1195-204. PubMed ID: 8413324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human myeloma IgG half-molecules. Structural and antigenic analyses,
    Spiegelberg HL; Heath VC; Lang JE
    Biochemistry; 1975 May; 14(10):2157-63. PubMed ID: 50083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystals of the human heavy chain disease protein Riv and human Fc fragment are isomorphous: further evidence for conformational flexibility in the hinge region of immunoglobulins.
    Mariuzza RA; Poljak RJ; Mihaesco C; Mihaesco E
    J Mol Biol; 1983 Apr; 165(3):559-61. PubMed ID: 6405046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unusual sequence of immunoglobulin L-chain rearrangements in a gamma heavy chain disease patient.
    Hauke G; Schiltz E; Bross KJ; Hollmann A; Peter HH; Krawinkel U
    Scand J Immunol; 1992 Sep; 36(3):463-8. PubMed ID: 1519038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gamma heavy chain disease protein CHA: immunological and structural studies.
    Arnaud P; Wang AC; Gianazza E; Wang IY; Lasne Y; Creyssel R; Fudenberg HH
    Mol Immunol; 1981 May; 18(5):379-84. PubMed ID: 6796821
    [No Abstract]   [Full Text] [Related]  

  • 12. A new case of gamma-heavy chain disease (LIA protein) with deletion of the hinge region.
    Santoro C; De Marchi M; van Loghem E; de Lange G; Malfi G; Vitelli A; Carbonara AO
    Ric Clin Lab; 1984; 14(1):21-8. PubMed ID: 6427878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical and biosynthetic studies of a crystallizable human gamma 1 heavy-chain disease protein.
    Mihaesco E; Guglielmi P; Brouet JC; Mihaesco C
    Scand J Immunol; 1983 Aug; 18(2):145-52. PubMed ID: 6410498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new case of gamma-heavy chain disease.
    Gallart MT; Canals J; CaƱadell E; Cortez L; Moragas A; Schwartz S
    Acta Haematol; 1978; 59(5):262-76. PubMed ID: 417549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin heavy-chain-associated amyloidosis.
    Eulitz M; Weiss DT; Solomon A
    Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6542-6. PubMed ID: 2118650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary structure of human gamma 3 immunoglobulin deletion mutant: gamma 3 heavy-chain disease protein Wis.
    Frangione B; Rosenwasser E; Prelli F; Franklin EC
    Biochemistry; 1980 Sep; 19(18):4304-8. PubMed ID: 6774747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of gamma 3 heavy chain disease with vacuolated plasma cells: a clinical, immunological, and ultrastructural study.
    Feremans W; Caudron M; Bieva C
    J Clin Pathol; 1979 Apr; 32(4):334-43. PubMed ID: 109474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The structural heterogeneity among degraded gamma heavy chain disease proteins.
    Franklin EC
    J Immunol; 1978 Dec; 121(6):2582-3. PubMed ID: 102697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gamma heavy chain disease: clinical aspects and characterization of a deleted, noncovalently linked gamma1 heavy chain dimer (BAZ).
    Faguet GB; Barton BP; Smith LL; Garver FA
    Blood; 1977 Apr; 49(4):495-505. PubMed ID: 402960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Isolation of a gamma heavy chain fragment from normal human serum].
    Irurzun PL; Miranda MP
    Allergol Immunopathol (Madr); 1976; 4(2):111-20. PubMed ID: 820178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.